Thomasville National Bank Precision Biosciences Inc Transaction History

Thomasville National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 02, 2021	SELL	$8.07 - $12.52 $442,704 - $686,822	-54,858 Closed	0 $0
Q1 2021 Apr 01, 2021	SELL	$8.57 - $15.79 $172,616 - $318,042	-20,142 Reduced 26.86%	54,858 $331,000
Q3 2020 Oct 01, 2020	BUY	$4.65 - $8.73 $47,160 - $88,539	10,142 Added 15.64%	75,000 $462,000
Q2 2020 Jul 01, 2020	BUY	$4.66 - $8.7 $302,238 - $564,264	64,858 New	64,858 $540,000
Q1 2020 Apr 02, 2020	SELL	$5.05 - $15.01 $327,532 - $973,518	-64,858 Closed	0 $0
Q4 2019 Jan 07, 2020	BUY	$6.32 - $19.66 $409,902 - $1.28 Million	64,858 New	64,858 $901,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $805M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

Stay updated on Thomasville National Bank with notifications on news.